Editorial: Rheumatology at the center of coronavirus disease 2019: pathogenesis, treatment, and clinical care.

Haberman, Rebecca H; Jaros, Brian D; Scher, Jose U

Haberman, Rebecca H; Jaros, Brian D; Scher, Jose U.

Haberman RH; Division of Rheumatology.
Jaros BD; Department of Medicine, New York University Grossman School of Medicine, New York City, New York, USA.
Scher JU; Division of Rheumatology.

Curr Opin Rheumatol ; 33(5): 409-411, 2021 09 01.

Article in English | MEDLINE | ID: covidwho-1467418

Subject(s)

Antirheumatic Agents; COVID-19; Rheumatic Diseases; Rheumatology; Antirheumatic Agents/therapeutic use; Humans; Rheumatic Diseases/drug therapy; SARS-CoV-2

Fulltext

XML

PubMed Links

Search on Google

Full text: Available Collection: International databases Database: MEDLINE Main subject: Rheumatology / Rheumatic Diseases / Antirheumatic Agents / COVID-19 Type of study: Prognostic study Limits: Humans Language: English Journal: Curr Opin Rheumatol Journal subject: Rheumatology Year: 2021 Document Type: Article

Similar

MEDLINE

LILACS

LIS

Fulltext

XML

PubMed Links

Search on Google